Clean Beat, Guarded Guide: A Best-in-Class Compounder We'd Rather Own Cheaper

Results vs. Consensus

Year-over-Year (Q4 2025 vs. Q4 2024)

Sequential (Q4 2025 vs. Q3 2025)

Sequential softness is seasonal: normal Q4 volume declines were offset by project startups, leaving volumes flat quarter-on-quarter. The QoQ picture is not the story; the annual guide is.

Assessment — Revenue

The revenue beat is real but flattered by currency. Of the 6% headline growth, 3 points came from FX (a weaker dollar, chiefly against the euro), 2 from price, and 1 from bolt-on acquisitions, leaving core organic volume growth of just 1%. That is the tension in the Linde story right now: the top line looks healthy, but the underlying volume engine is barely turning. The Americas (+8% headline, +4% underlying) and APAC (+3%, +2% underlying) did the work; EMEA volumes contracted. For a business whose long-term algorithm assumes low-single-digit volume growth to layer on top of pricing, 1% organic volume in Q4 is a reminder that the industrial cycle has not yet turned.

Assessment — Margins

The 40 bps YoY dip in adjusted operating margin to 29.5% looks worse than it is. Management attributed the quarterly dilution to the timing of other income, which fell more than $30M year-on-year; the more durable read is the full-year figure, where adjusted operating margin expanded 30 bps to 29.8%, squarely inside the company's 30–50 bps annual target. Given the fresh restructuring actions and continued productivity work, management guided margin expansion in 2026 to exceed the normal 30–50 bps range. We take that as credible: Linde's decentralized, self-sufficient regional model lets it pull cost out region-by-region without disrupting the rest of the network, and the SG&A discipline shown in 2025 (underlying SG&A up only ~1.5% against ~3% merit inflation) is the proof point.

Assessment — EPS

Adjusted EPS of $4.20 (+6% YoY) beat by three cents, an unremarkable margin of victory but the fourth consecutive quarterly beat. The composition matters more than the size: this is EPS growth manufactured from pricing, productivity and buybacks in a zero-volume-growth environment, which is precisely the resilience the Linde bull case rests on. The flip side is that when the top-line contribution is this thin, the "beat" is a rounding exercise, and the market is right to look past it to the 2026 setup, where the same self-help levers are being asked to deliver 6–9% growth again. The stock is not being priced on Q4; it is being priced on whether 2026 can eventually become a double-digit-growth year.

Segment Performance

Americas

The Americas is the engine and the tell. Sales rose 8% and underlying growth of 4% (3% price, 1% volume) was led by the electronics end market, with commercial space also standing out. Management repeatedly described the U.S. as "a really resilient market" with sales up across almost every end market and manufacturing "stable." The nuance is in the leading indicators: hard-goods automation-equipment sales rose again, but consumables and gas volumes remain flat-to-down, which management reads as customers investing ahead of a recovery they can sense but not yet see.

"The US, and I've said this over and over again, proven to be a really resilient market. Sales are up across almost every end market. Obviously, electronics, commercial space, kind of stand out." — Sanjiv Lamba, CEO

Assessment: At a 30.9% margin and growing on both price and volume, the Americas is doing exactly what the model needs. The optionality is the second-derivative: if the automation-equipment restocking converts into consumables demand, the Americas is where a volume inflection shows up first.

EMEA

EMEA is the drag, but a high-quality one. Underlying sales fell 2% as 1% pricing was overwhelmed by a 3% volume decline concentrated in chemicals & energy. Yet the segment still posted the highest margin in the company, 35.4%, testament to a portfolio that has been restructured through multiple down-cycles. Management sees "broad-based weakness" persisting with "no catalyst" for a substantive European recovery, tempering the modest uptick in recent German manufacturing data.

"Based on what we see at the moment, I have to say that the market continues to see broad-based weakness. That's been the theme for a number of quarters over the last couple of three years now." — Sanjiv Lamba, CEO

Assessment: EMEA is the clearest example of Linde's ability to defend margin while volumes shrink. The 35.4% margin on falling volumes is impressive, but it also means the incremental margin on any European volume recovery would be substantial. This segment is coiled; it just has no near-term spring.

APAC

APAC grew 3% (2% underlying, all volume), led by electronics and chemicals & energy including project startups. The regional story is China bottoming (merchant volumes to end customers reportedly grew faster than the published 5% IP number last quarter), India strong across all end markets, and ASEAN the disappointment, flattish and dragged by its linkage to China.

"In my assessment, the China markets that we supply and work with closely are largely bottoming out." — Sanjiv Lamba, CEO

Assessment: A 29.1% margin and 2% volume growth make APAC the quiet contributor. The China-bottoming call is the one to watch: if it holds through the Chinese New Year distortion into Q1, it removes one of the two big volume overhangs on the stock (the other being Europe).

Engineering

Engineering sales fell 2% to $615M at a 16.7% margin, with order intake of $434M and a third-party sale-of-equipment backlog of $2.7B. This is the segment bearing the brunt of the Q4 restructuring, which management said is "predominantly related to headcount actions" and concentrated in engineering as the company reorganizes around third-party opportunities.

Assessment: Engineering is the most cyclical, lowest-margin piece and the least important to the equity story; the restructuring here is a structural right-sizing, not a demand signal. We would not extrapolate the 2% decline.

Key Topics & Management Commentary

Overall Management Tone: Management struck a deliberately guarded posture, describing the 2026 guide in its own words as "guarded, prudent, and conservative" and anchoring it at zero base-volume growth so investors could layer in their own macro view. The confidence was reserved for the controllables, backlog, pricing, productivity and capital allocation, while the tone on the industrial cycle was cautious-but-thawing, with the CEO characterizing himself as "slightly more positive" on industrial activity than a year ago without committing to a recovery timeline.

1. The 2025 "Study in Contrast"

The CEO framed 2025 as a bifurcated economy: an AI/digital-infrastructure boom on one side and a retrenchment in traditional industrial markets (manufacturing, metals, chemicals, energy) on the other. That divergence is the backdrop for everything else in the quarter, it explains why price and electronics carried the results while base industrial volumes stagnated.

"The economic environment in 2025 was a study in contrast. On one hand, exuberant investment in AI and digital infrastructure drove unprecedented activity. On the other hand, traditional industrial markets like manufacturing, metals, chemicals, and energy faced continued retrenchment." — Sanjiv Lamba, CEO

Assessment: This is the honest framing, and it cuts both ways. Linde is well-exposed to the growth side (electronics, clean energy, space) but the majority of its volume base still sits in the retrenching side. Until traditional industrial recovers, the algorithm runs on price and self-help.

2. Pricing Power in a Deflationary Tape

Price attainment was 2% in Q4, in line with globally weighted inflation once helium and China deflation are excluded. Management reiterated its expectation to price at or around weighted CPI in every region in 2026, extending a streak it says now spans 25 years of positive pricing.

"That's a long-term trend. As you know, we've had positive pricing for twenty-five years." — Sanjiv Lamba, CEO

Assessment: Consistent CPI-plus pricing through a deflationary Chinese market and a weak Europe is the single most important pillar of the resilience case. As long as pricing holds, Linde can compound EPS through a flat-volume environment. This pillar is intact.

3. Record $10B Backlog and the "Shrink Before It Grows" Dynamic

The total project backlog stands at a record $10.0B (excluding over $0.5B of space-related propellant investment). The sale-of-gas portion will decline in 2026 as large projects (OCI, Woodside) start up and begin contributing revenue; management expects $2.5–$3B of projects to convert to revenue this year and is targeting a return toward the $7B sale-of-gas backlog level as new wins, including anticipated fab awards, replenish it.

"The best backlog is one that shrinks before it grows back up again... the target is to get back to that $7 billion. We'll see whether we can dare cross it." — Sanjiv Lamba, CEO

Assessment: A shrinking sale-of-gas backlog in 2026 is a feature, not a bug, it means contracted growth is converting to earnings. The risk is replenishment: the path back to $7B depends on landing the "signature fab wins" management says are close. Watch for those announcements as the key 2026 catalyst.

4. Electronics and the TSMC Arizona Ramp

Electronics was the standout growth end market in both the Americas and APAC. On the marquee project, management confirmed its units at TSMC's Arizona Fab 1 are fully utilized and Fab 2 is ramping "exactly as planned," with the next round of fabs "under discussion." Critically, advanced nodes raise gas intensity two ways: more gas per node, and new gases used in larger quantities.

"The commitment to major investments in advanced nodes at Phoenix is strong, and with that comes higher gas intensity... because we're going to advanced nodes, the intensity or the usage of gas goes up per node. But more importantly, we also see new gases being introduced and used in much bigger quantities." — Sanjiv Lamba, CEO

Assessment: Electronics is the highest-conviction secular pillar. Rising gas intensity per node means Linde's electronics revenue can grow faster than fab wafer starts, and the on-site contract structure locks in decades of take-or-pay volumes. This is where the durable growth optionality lives.

5. Commercial Space / Rocket Propellants

Management fielded multiple questions on space, disclosing more than $0.5B invested outside the reported backlog, hubs in Texas and Florida, a new Brownsville plant started in early January, and involvement in an estimated 65–75% of the 189 launches last year. It is growing double-digits but is not yet a needle-mover for a company Linde's size.

"I'm looking forward to having a billion-dollar business... I expect to see that happen in the next few years. But it isn't big enough to move the needle for Linde as a company overall. So it's in the guidance. We are excited about it. Double-digit growth." — Matthew White, CFO

Assessment: Space is a genuine secular tailwind and a nice narrative, but management is right to downplay its near-term financial weight. It is optionality, not a 2026 earnings driver. We would not pay up for it today.

6. Restructuring: Structural, Not Cyclical

Linde booked a ~$230M restructuring charge in Q4, predominantly headcount actions concentrated in engineering. Management was explicit that this is structural, not cyclical, headcount that is "not expected to come back," with the bulk of the benefit landing in H2 2026 given the typical ~2-year cash payback.

"When we put it into restructuring, we view it as structural. Right? We view this as changing our organization... These restructuring charges we took are predominantly related to headcount actions around the world." — Matthew White, CFO

Assessment: Structural cost-out ahead of a potential volume recovery is the right sequencing, it front-loads the cost pain and positions for operating leverage when volumes turn. It is also a tacit admission that management does not expect certain regions (Europe) to recover soon.

7. Margin Trajectory: Beating the Long-Term Range

Full-year adjusted operating margin expanded 30 bps to 29.8%. Management guided 2026 margin expansion to exceed the normal 30–50 bps range, combining restructuring benefits with ongoing productivity.

"My expectation remains that we will be above the long-term margin range that we normally offer you... My view is in 2026, we will beat that number." — Sanjiv Lamba, CEO

Assessment: An above-trend margin commitment is a rare piece of explicit forward confidence in an otherwise guarded call. It is achievable given the self-help pipeline, and it is the mechanism by which Linde delivers 6–9% EPS growth on 0% assumed volume.

8. Geographic Divergence

The CEO's "walk around the world" was the analytical centerpiece: U.S. resilient (automation restocking, cautious consumables), LatAm stable with Brazil strong, Canada flat with no catalyst, China bottoming, India strong (aided by an EU FTA and resolution of U.S. tariff issues), ASEAN disappointing, Australia stabilizing off a weak 2025.

"Growth remains geographically uneven, and we need to adjust our organization to reflect that." — Sanjiv Lamba, CEO

Assessment: The mosaic is net-improving but far from a synchronized recovery. Two of the three big volume pools (Europe, ASEAN) remain stalled; the swing factors for 2026 are U.S. manufacturing conversion and whether China's bottoming holds.

9. Helium and Rare Gas Headwind

Helium pricing has been high-single-digit negative for several quarters and management sees "nothing different" in 2026, calling helium "long in the medium term." Combined, helium and rare gas were a 1–2% EPS headwind in 2025, toward the upper end of that range, though rare gas is improving with the electronics recovery.

"When you combine those two, the kind of range we've laid out is about a one to 2% headwind on EPS. I would say towards the upper end of that range." — Matthew White, CFO

Assessment: Helium is a low-single-digit share of the portfolio and the drag is well understood, but it is a persistent one. Rare-gas improvement is the offsetting positive tied to electronics. Net, a modest but not thesis-altering headwind.

10. Capital Allocation and the Buy-the-Dip Buyback

Linde returned $7.4B to shareholders in 2025, invested ~$6B in growth (half toward secured backlog/acquisitions), and explicitly stepped up Q4 buybacks to ~$1.4B to exploit a share-price decline. The board raised the dividend 7% to $1.60/quarter, the 33rd consecutive annual increase. Bolt-on M&A (~$400–500M/year) contributes roughly 1% to the top line.

"We stepped up share repurchases in the fourth quarter to $1.4 billion as we saw an attractive buying opportunity from the stock decline." — Matthew White, CFO

Assessment: This is textbook capital discipline: buy more stock when it is cheaper, grow the dividend every year, and justify acquisitions on synergies rather than speculative growth. The buyback opportunism is a mild positive signal on management's own view of intrinsic value.

11. The 2026 Guidance Philosophy

The 2026 guide (6–9% adjusted EPS growth) sits below the "double-digit" path floated at December's investor day and below the Street midpoint. Management deliberately anchored the midpoint at 0% base-volume growth, framing the guide as an invitation for investors to insert their own macro views.

"I've said before that heroes aren't made in the first quarter, so we want to remain vigilant and guarded as the 2026 landscape starts to take shape." — Matthew White, CFO

Assessment: This is classic Linde sandbagging, the company has a long history of guiding conservatively and beating. But sandbagging only works as a stock catalyst if volumes cooperate; a 0%-volume guide with upside optionality is exactly what a fully-valued stock does not want to hear on the day, hence the sell-off.

Guidance & Outlook

The full-year guide of $17.40–$17.90 implies roughly 7% growth at the midpoint off the 2025 adjusted EPS base of $16.46, built on a 1% FX tailwind and 0% base-volume assumption. Management was clear that the algorithm is powered by "capital contribution" (backlog startups plus acquisitions) and "management actions" (price plus productivity), with the macro left neutral. The CFO conceded the upper end of the range "maybe catches the low eight to twelve percent" the company aspires to ex-macro, leaving explicit room for a beat if industrial volumes turn.

Implied quarterly ramp: With Q1 guided to a $4.25 midpoint, the remaining three quarters must average ~$4.47 to reach the $17.65 full-year midpoint, a back-half-weighted profile consistent with restructuring benefits landing in H2. This is a shape that rewards patience and punishes anyone modeling a linear year.

Street at: Consensus sat near $17.83 for FY2026 and $4.24 for Q1 entering the print. The Q1 guide is essentially in line; the full-year midpoint is ~1% light, with the high end just above Street. That gap, quality quarter but a full-year guide that does not clear the Street at the midpoint, is the proximate cause of the sell-off.

Guidance style: Conservative and consistent with a decade-plus pattern of guiding below aspiration and beating. The 0%-volume anchor is a floor, not a forecast.

Analyst Q&A Highlights

Europe pricing and the search for a catalyst

The opening line of questioning pressed on whether EMEA can hold ~2% pricing into 2026 given a Q4 slowdown to +1%, and whether any recovery catalyst is visible. Management defended the pricing track record while pointedly refusing to call a European turn.

Q: "Just on Europe, are you seeing any signs of progress in that region? And I did see that pricing did slow to plus 1% in Q4. Do you think you can still get pricing of roughly plus 2% in the region during 2026?"
— David Begleiter, Deutsche Bank

A: "The market continues to see broad-based weakness... I expect them to find pricing in line with their weighted CPI... The complexity of Europe... provides a bit of a skeptical view from our perspective till we actually see it happen on the ground."
— Sanjiv Lamba, CEO

Assessment: Management is confident on pricing (CPI-linked) but has no visibility on volumes. The refusal to call a bottom in Europe is prudent and consistent with the structural restructuring being taken there.

The walk around the world and end-market growth

A recurring line of questioning asked management to reconcile the all-green end-market slide with a 0%-volume guide, essentially, what does the CEO's gut say each region grows this year?

Q: "You're not putting any growth in your estimates. But what are you seeing?... what does your gut say your different end markets and your different geographies end up growing this year?"
— Duffy Fischer, Goldman Sachs

A: "I am today slightly more positive on the industrial activity that I foresee for this year... But fair to say we've been very conservative in how we are looking at the markets, and you'll see that reflected in the guidance as well."
— Sanjiv Lamba, CEO

Assessment: The most important exchange of the call. Management's gut is more constructive than the guide, which frames the 0%-volume assumption as conservatism rather than pessimism, and quantifies the potential upside investors should watch for through 2026.

Backlog trajectory and the path back to $7B

With large projects starting up, questioning focused on whether the sale-of-gas backlog settles at a lower "new normal" or rebuilds toward prior peaks.

Q: "With Beaumont start-ups, I guess we would be coming down towards $5.5 billion... Is $5.5 billion the new norm, or would you hope to get back closer to $7 billion in the next year or so?"
— Laurent Favre, BNP Paribas

A: "We will be heading towards that $7 billion mark... Some really large wins around fabs that I'm hopeful that we will be able to get to a point of being able to announce... soon."
— Sanjiv Lamba, CEO

Assessment: Management is effectively pre-announcing fab wins. If those land in H1 2026, the backlog-replenishment concern evaporates and it becomes a bull catalyst. The credibility of this claim is the single biggest swing factor on the growth pillar.

Restructuring payback and the 2026 margin uplift

Questioning tried to size the margin benefit from the $230M restructuring charge and the OpEx-inflation trajectory into 2026.

Q: "If we take that $230 million, can we assume a roughly one-to-one ratio to savings? If we do that, it points to something like a 70 basis point margin uplift in '26... Is that reasonable?"
— Toni Jones, Rothschild & Co Redburn

A: "Our restructuring paybacks on a cash basis tend to be on average about two years... My expectation remains that we will be above the long-term margin range... in 2026, we will beat that number."
— Sanjiv Lamba, CEO

Assessment: Management would not confirm the full 70 bps but committed to above-range (30–50 bps) expansion. The ~2-year payback implies benefits build through H2, supporting the back-half-weighted EPS ramp.

Space CapEx: upside or already embedded?

Questioning probed whether the 17% CapEx step-up for 2026 includes the space build-out, and how to think about the opportunity's scale.

Q: "I wanted to ask if any of [the space opportunity] is contributing to the CapEx increase you're projecting for 2026. It's not backlog. So is it in there? Is it upside?"
— Josh Spector, UBS

A: "The CapEx in the backlog does not include about half a billion of projects that we have invested in... It is factored into the guidance. It's a secular trend for sure. But... it isn't big enough to move the needle for Linde as a company overall."
— Matthew White, CFO

Assessment: Space capital is in the guide but deliberately not sized as a 2026 earnings driver. Correctly treated as multi-year optionality; investors paying up for space today are paying for a business that is not yet a billion dollars.

Helium drag and the U.S. manufacturing PMI turn

A two-part question tied the macro (U.S. PMI flipping positive) to the micro (helium's EBIT drag), asking whether Linde can perceive an acceleration and how helium trends in 2026.

Q: "Manufacturing PMIs in the US went from negative to positive. Is that something that your business can perceive?... And can you discuss how much helium was a drag... in 2025? And how do you expect helium to perform in 2026?"
— Jeff Zekauskas, JPMorgan

A: "The ISM, PMI have shown a positive trend... I'd just say it's too early to tell... On helium impact, I see nothing different. Helium is gonna be long in the medium term at least."
— Sanjiv Lamba, CEO

Assessment: Management will not let a one-month PMI print change its posture, and it flagged helium as a continuing, well-understood drag. Both answers reinforce the conservative framing rather than the recovery narrative.

TSMC Arizona Fab 2 timing and gas intensity

Questioning sought a timeline for Linde's unit at TSMC Fab 2 and the profitability implications of rising gas intensity from Fab 1 to Fab 2.

Q: "Could you please provide a timeline update on when you anticipate your unit to start up at TSMC's Arizona Fab 2? And could you remind on how gas intensity increases from Fab 1 to Fab 2?"
— Eric Bois, Evercore ISI

A: "Fab 1 fully utilized. Fab 2 ramping up. Exactly as planned. The next round of fabs is now under discussion... because we're going to advanced nodes, the intensity or the usage of gas goes up per node... we also see new gases being introduced and used in much bigger quantities."
— Sanjiv Lamba, CEO

Assessment: The Arizona ramp is on schedule and the intensity math is favorable, gas revenue can outgrow wafer volume. This is the tangible proof point behind the electronics pillar and the anticipated fab wins.

What They're NOT Saying

1. No sale-of-gas backlog figure disclosed: Management gave the $10.0B total backlog and confirmed a decline is coming as projects start up, but declined to state the current sale-of-gas number, letting analysts infer ~$5.5B. Withholding the precise figure on a quarter when it is set to shrink is a modest tell.
2. The "signature fab wins" are teased but unsigned: The CEO is "highly confident" and "hopeful" about imminent fab announcements, but nothing is in the backlog yet. Confidence language without signed contracts is a promise the market will hold against the H1 2026 record.
3. No quantified bridge to the "double-digit" aspiration: Management acknowledged the December investor-day 10%+ framing but would not bridge the gap between that and the 6–9% guide beyond "macro." What specifically has changed since December is left vague.
4. ROC trajectory soft-pedaled: ROC of 24.2% still leads the industry but is down as capital intensity rises; management flagged it will stay "low to mid-20%" for "the next few years" without dwelling on the multi-year deceleration from the high-20s.
5. The six-point growth blueprint stays a black box: Asked to detail the formalized "Chrome six" growth plan from the December investor day, the CEO declined to "tease," offering no specifics or quantification.

Market Reaction

• Pre-print setup: LIN closed at $473.33 on Feb 4 (the print hit before the open on Feb 5). The stock entered the print up 11.0% YTD, up 8.3% over the trailing 30 days and up 4.3% over the trailing 12 months, near the top of its $389.38–$483.59 52-week closing range. The S&P 500 was up just 0.5% YTD, so LIN had meaningfully outrun the tape into the quarter.
• Reaction-day session (Feb 5, BMO): Shares opened down 0.5% at $471.07, traded as low as $459.26, and closed at $459.69, down 2.9% (-$13.64) on 3.5M shares versus a 2.3M 30-day average (1.5x). The S&P 500 fell 1.2% the same day, so roughly a third of the move was market beta; the balance was stock-specific.

This is a textbook "sell the news" reaction on a stock priced for more than it delivered. A clean double beat was never going to move a name that had already rallied 11% YTD; what mattered was the forward guide, and a full-year midpoint ~1% below the Street, framed in the language of caution, gave a fully-valued stock a reason to give back a month's worth of gains. The restructuring charge and the below-aspiration guide combined to shift the near-term narrative from "compounder re-accelerating" to "compounder waiting on the cycle," and at ~26x forward that narrative shift is worth a few points. We read the move as valuation air coming out, not a fundamental crack.

Street Perspective

Debate: Does the premium multiple still make sense?

Bull view: At ~26x the 2026 midpoint, Linde deserves a premium for best-in-class ROC (24.2%), a 33-year dividend-growth streak, oligopoly pricing power, and a record backlog skewed to secular electronics/clean-energy/space demand. Quality compounders rarely get cheap, and the pullback is an entry.

Bear view: A ~26x multiple on 6–9% EPS growth is a PEG north of 3x. The multiple already discounts a volume recovery that has not arrived and may not in 2026; if the industrial cycle stays flat, the stock is a high-quality bond proxy priced like a growth stock.

Our take: The bears have the near-term math. The quality is not in question, but the price leaves no margin of safety and no cushion if 2026 volumes disappoint. We would need either a de-rating toward the low-20s or a confirmed volume inflection to turn constructive. Hold.

Debate: Is 2026 the volume inflection?

Bull view: U.S. PMI has flipped positive, China is bottoming, hard-goods automation is restocking, and India is accelerating. With a 0%-volume guide, any real volume adds directly to a beat, and Linde's 2021 playbook (7–8% volume → 30% EPS) shows the leverage.

Bear view: Europe and ASEAN remain stalled with "no catalyst," consumables and gas volumes are still flat-to-down, and management itself will not call a turn. The green shoots are the same ones investors have been promised for two years.

Our take: The mosaic is net-improving but unconfirmed. Management's own posture, structurally restructuring Europe while calling itself "slightly more positive", tells you they see a gradual thaw, not an inflection. We would treat a volume recovery as 2027 optionality, not a 2026 base case.

Debate: How durable and convertible is the backlog?

Bull view: A record $10.0B backlog plus $0.5B of space, two-thirds tied to contracted clean-energy projects, with $2.5–$3B converting to revenue in 2026 and "signature fab wins" imminent, is the most visible growth pipeline in the group and underwrites years of contracted, take-or-pay volume.

Bear view: Backlog is set to shrink in 2026, the promised fab wins are unsigned, clean-energy projects carry execution and policy risk, and a chunk of the backlog is lower-return relative to Linde's historical on-site economics.

Our take: The backlog is a genuine strength and the "shrink before it grows" framing is credible, but the replenishment depends on wins management has teased without signing. We give the growth pillar the benefit of the doubt while flagging H1 2026 fab announcements as the show-me catalyst.

Model Update Needed

Valuation impact: At the $459.69 reaction close, LIN trades at ~26x the FY26 adjusted-EPS midpoint and ~28x trailing 2025, with a ~1.4% dividend yield. Our 12-month fair value is approximately $475 (roughly 27x the FY26 midpoint), about +3% from spot, i.e., a market-perform total return once the ~1.4% yield is added. That is the arithmetic behind the Hold: a wonderful business at a price that offers little more than the market.

Thesis Scorecard Post-Earnings

Overall: The operating thesis (quality, pricing, backlog, capital allocation) is fully intact and arguably strengthened by the buyback opportunism and above-range margin guide. The valuation and volume risks are equally confirmed. Net, this is a high-quality business executing well into a price that has already discounted the quality.

Action: Initiate at Hold. We are buyers on a de-rating toward the low-20x range or on confirmation of a volume inflection (signed fab wins, a sustained China/U.S. volume turn). At ~26x with a 0%-volume guide, we would rather own the quality cheaper.